首页> 外文期刊>American Journal of Physiology >Regulation of fluid reabsorption in rat or mouse proximal renal tubules by asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase 1
【24h】

Regulation of fluid reabsorption in rat or mouse proximal renal tubules by asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase 1

机译:通过不对称二甲基碱和二甲基喹硫氨酸二甲基氨基水解酶1调节大鼠或小鼠近端肾小管中的液体重吸收

获取原文
获取原文并翻译 | 示例
           

摘要

Nitric oxide prevents hypertension yet enhances proximal tubule Na+ reabsorption. Nitric oxide synthase is inhibited by asymmetric dimethylarginine (ADMA) that is metabolized by dimethylarginine dimethylaminohydrolase (DDAH) whose type 1 isoform is expressed abundantly in the proximal tubule (PT). We hypothesize that ADMA metabolized by DDAH-1 inhibits fluid reabsorbtion (Jv) by the proximal tubule. S2 segments of the PT were microperfused between blocks in vivo to assess Jv in anesthetized rats. Compared with vehicle, microperfusion of ADMA or Nω-nitro-l-arginine methyl ester (l-NAME) in the proximal tubule reduced Jv dose dependently. At 10?4 mol/l both reduced Jv by ~40% (vehicle: 3.2?±?0.7 vs. ADMA: 2.1?±?0.5, P < 0.01 vs. l-NAME: 1.9?±?0.4 nl·min?1·mm?1, P < 0.01; n = 10). Selective inhibition of DDAH-1 in rats with intravenous L-257 (60 mg/kg) given 2 h before and L-257 (10?5 mol/l) perfused in the proximal tubule for 5 min reduced Jv by 32?±?4% (vehicle: 3.2?±?0.5 vs. L-257: 2.2?±?0.5 nl·min?1·mm?1; P < 0.01) and increased plasma ADMA by ≈50% (vehicle: 0.46?±?0.03 vs. L-257: 0.67?±?0.03 μmol/l, P < 0.0001) without changing plasma symmetric dimethylarginine. Compared with nontargeted control small-interference RNA, knock down of DDAH-1 in mice by 60% with targeted small-interference RNAs (siRNA) reduced Jv by 29?±?5% (nontargeted siRNA: 2.8?±?0.20 vs. DDAH-1 knockdown: 1.9?±?0.31 nl·min?1·mm?1, P < 0.05). In conclusion, fluid reabsorption in the proximal tubule is reduced by tubular ADMA or by blocking its metabolism by DDAH-1. L-257 is a novel regulator of proximal tubule fluid reabsorption.
机译:一氧化氮可防止高血压且增强近端小管Na + Reableplating。通过非对称二甲基碱(ADMA)抑制一氧化氮合成酶,其由二甲基甘氨酸二甲基氨基酰氯酶(DDAH)代谢,其类型1同种型在近端小管(Pt)中大量表达。我们假设DDAH-1代谢的ADMA通过近端小管抑制流体Regsorbtion(JV)。 Pt的S2段在体内嵌段之间进行微量熔,以评估麻醉大鼠的JV。与载体相比,在近端小管中的ADMA或Nω-硝基-L-精氨酸甲酯(L-NAME)的微孔依赖性降低了JV剂量。在10?4 mol / l均减少JV〜40%(车辆:3.2?±±0.7 Vs. ADMA:2.1?±0.5,P <0.01 Vs. L-name:1.9?±0.4 nl·min? 1·mm?1,p <0.01; n = 10)。在近端小管中灌注2小时的静脉内L-257(60mg / kg)的大鼠中DDAH-1在大鼠中的选择性抑制DDAH-1在近端小管中灌注5分钟的JV±±? 4%(车辆:3.2?±±0.5与L-257:2.2?±0.5nl·min?1·mm?1; p <0.01),并增加血浆ADMA≈50%(车辆:0.46≤0.46? 0.03与L-257:0.67?±0.03μmol/ L,P <0.0001)而不改变血浆对称二甲基碱。与非靶向控制小干扰RNA相比,用靶向小干扰RNA(siRNA)将DDAH-1的DDAH-1敲低60%(siRNA),减少了JV 29?±5%(Nontargeted siRNA:2.8?±0.20 Vs. DDAH -1敲低:1.9?±α0.31 nl·min?1·mm?1,p <0.05)。总之,近端小管中的流体重吸收通过管状氧化剂或通过DDAH-1阻断其代谢。 L-257是近端小管液重吸收的新型调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号